Carlos C Crestani Selected Research

(2- (2',6'- dimethoxy)phenoxyethylamino)methylbenzo- 1,4- dioxane

1/2021	Both Prelimbic and Infralimbic Noradrenergic Neurotransmissions Modulate Cardiovascular Responses to Restraint Stress in Rats.
9/2012	Lateral septal area α1- and α2-adrenoceptors differently modulate baroreflex activity in unanaesthetized rats.
10/2009	Insular cortex alpha1-adrenoceptors modulate the parasympathetic component of the baroreflex in unanesthetized rats.
12/2008	Bed nucleus of the stria terminalis alpha(1)-adrenoceptor modulates baroreflex cardiac component in unanesthetized rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carlos C Crestani Research Topics

Disease

23	Tachycardia (Tachyarrhythmias) 01/2022 - 01/2007
19	Bradycardia 01/2021 - 01/2007
7	Body Weight (Weight, Body) 01/2019 - 01/2015
4	Hypertension (High Blood Pressure) 12/2017 - 11/2011
2	Hypertrophy 02/2018 - 02/2015
1	Glioblastoma (Glioblastoma Multiforme) 04/2022
1	Neoplasms (Cancer) 04/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2022
1	Fatigue 12/2021
1	Necrosis 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Hemorrhage 01/2021
1	Hemorrhagic Shock 01/2021
1	Atrophy 12/2017
1	Fibrosis (Cirrhosis) 01/2014
1	Dehydration (Water Stress) 07/2013
1	Cardiomegaly (Heart Hypertrophy) 03/2012
1	Hypotension (Low Blood Pressure) 06/2011
1	Ganglion Cysts (Ganglion) 02/2011

Drug/Important Bio-Agent (IBA)

5	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 11/2020 - 12/2008
5	CorticosteroneIBA 11/2018 - 10/2012
4	Arginine (L-Arginine)FDA Link 12/2021 - 01/2019
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 10/2014
4	(2- (2',6'- dimethoxy)phenoxyethylamino)methylbenzo- 1,4- dioxaneIBA 01/2021 - 12/2008
4	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 11/2020 - 12/2008
4	cobaltous chloride (cobalt(II)chloride)IBA 08/2010 - 12/2008
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 05/2009
3	antisauvagine 30IBA 01/2021 - 07/2017
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 02/2011
3	N-Methylaspartate (NMDA)IBA 01/2021 - 05/2009
3	Ethanol (Ethyl Alcohol)IBA 01/2021 - 07/2013
3	1,3- dihydroxy- 4,4,5,5- tetramethyl- 2- (4- carboxyphenyl)tetrahydroimidazole (NOR 1)IBA 11/2020 - 01/2019
3	LY 235959IBA 01/2020 - 05/2009
3	Testosterone (Sustanon)FDA Link 01/2014 - 03/2012
3	2-methoxyidazoxanIBA 01/2014 - 12/2008
2	CRF receptor type 1IBA 01/2022 - 01/2021
2	Hormones (Hormone)IBA 01/2021 - 07/2013
2	AM 251 (AM251)IBA 01/2021 - 10/2016
2	Losartan (Cozaar)FDA LinkGeneric 01/2021 - 01/2016
2	(3,6- dimethyl- 2- (2,4,6- trimethylphenoxy)pyridin- 4- yl)(1- ethylpropyl)amineIBA 01/2021 - 07/2017
2	Excitatory Amino Acid AntagonistsIBA 01/2021 - 08/2010
2	Vasopressins (Vasopressin)IBA 01/2021 - 06/2011
2	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 11/2020 - 01/2019
2	Vasoconstrictor AgentsIBA 10/2016 - 10/2014
2	7-nitroindazoleIBA 01/2015 - 01/2007
2	Fluoxetine (Prozac)FDA LinkGeneric 01/2015 - 11/2011
2	Propranolol (Inderal)FDA LinkGeneric 09/2012 - 12/2008
2	Glutamic Acid (Glutamate)FDA Link 08/2010 - 01/2007
2	2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA 11/2009 - 05/2009
1	LipidsIBA 04/2022
1	Docetaxel (Taxotere)FDA Link 04/2022
1	Pharmaceutical PreparationsIBA 04/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2022
1	Bevacizumab (Avastin)FDA Link 04/2022
1	Vitamin D FDA LinkGeneric 04/2022
1	CRF receptor type 2IBA 01/2022
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2022
1	valproic acid glucuronideIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2021
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2021
1	Soluble Guanylyl CyclaseIBA 11/2020
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2020
1	KT 5823IBA 01/2020
1	PD 123319IBA 01/2019
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2019
1	Sucrose (Saccharose)IBA 01/2019
1	cupric sulfide (CuS)IBA 11/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2017
1	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 10/2016
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 10/2016
1	GlucocorticoidsIBA 02/2015
1	Antidepressive Agents (Antidepressants)IBA 01/2015
1	Cocaine (Cocaine HCl)IBA 01/2014
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2012
1	AcidsIBA 06/2011
1	ent-16alpha-methoxykauran-19-oic acidIBA 06/2011
1	Kaurane DiterpenesIBA 06/2011
1	Carbachol (Carbastat)FDA Link 06/2011
1	Cholinergic AgonistsIBA 06/2011
1	Pentolinium Tartrate (Pentolonium Tartrate)FDA Link 02/2011
1	Atenolol (Tenormin)FDA LinkGeneric 08/2010
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 12/2008
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2007
1	pimagedine (aminoguanidine)IBA 01/2007

Therapy/Procedure

4	Intravenous Infusions 01/2021 - 10/2009
1	Controlled Hypotension 01/2021